A small personalized vaccine trial has made significant progress in treating late-stage kidney cancer patients. In the Phase 1 trial, all nine participants remained cancer-free after approximately three years of treatment with their customized vaccine. This promising result offers new hope for those diagnosed with advanced kidney cancer.
Source: https://endpts.com/small-personalized-vaccine-trial-sees-progress-in-late-stage-kidney-cancer